US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 7.500
- -0.120-1.57%
Close Nov 22 16:00 ET
- 7.612
- +0.112+1.49%
Post 20:01 ET
54.72MMarket Cap-571P/E (TTM)
7.600High7.405Low46.01KVolume7.500Open7.620Pre Close346.95KTurnover1.01%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.41P/B34.08MFloat Cap5.20252wk Low--Dividend TTM4.54MShs Float363.268Historical High--Div YieldTTM2.56%Amplitude5.200Historical Low7.540Avg Price1Lot Size
Kezar Life Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 7M | 0 | 7M | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --7M | --0 | --7M | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -32.52%21.95M | -18.23%21.9M | -3.32%23.71M | 57.72%112.24M | 41.77%28.4M | 71.86%32.53M | 64.09%26.78M | 54.45%24.52M | 30.19%71.16M | 42.05%20.03M |
| Selling and administrative expenses | -35.08%5.71M | -3.15%5.6M | 5.37%6.54M | 31.69%26.54M | 11.30%5.76M | 73.46%8.79M | 16.23%5.79M | 25.78%6.21M | 28.17%20.15M | 19.74%5.18M |
| -General and administrative expense | -35.08%5.71M | -3.15%5.6M | 5.37%6.54M | 31.69%26.54M | 11.30%5.76M | 73.46%8.79M | 16.23%5.79M | 25.78%6.21M | 28.17%20.15M | 19.74%5.18M |
| Research and development costs | -31.58%16.24M | -22.39%16.3M | -6.26%17.17M | 68.00%85.7M | 52.38%22.64M | 71.27%23.74M | 85.08%21M | 67.38%18.32M | 31.01%51.01M | 51.92%14.86M |
| Operating profit | 14.02%-21.95M | 18.23%-21.9M | 3.32%-23.71M | -47.88%-105.24M | -41.77%-28.4M | -34.87%-25.53M | -64.09%-26.78M | -54.45%-24.52M | -30.19%-71.16M | -42.05%-20.03M |
| Net non-operating interest income expense | -32.55%1.64M | -25.85%1.84M | -11.70%2.05M | 226.86%9.55M | 25.69%2.33M | 124.44%2.42M | 1,720.59%2.48M | 1,692.47%2.33M | 9,979.31%2.92M | 1,800.00%1.85M |
| Non-operating interest income | -27.73%2.04M | -21.81%2.24M | -8.98%2.45M | 170.30%11.1M | 23.89%2.73M | 102.88%2.82M | 601.23%2.86M | 2,395.37%2.7M | 2,085.11%4.11M | 4,304.00%2.2M |
| Non-operating interest expense | 1.77%403K | 4.16%401K | 8.11%400K | 30.80%1.55M | 14.33%399K | 27.74%396K | 41.54%385K | 45.67%370K | 645.28%1.19M | 119.50%349K |
| Other net income (expense) | -1.48M | -6.19M | ||||||||
| Special income (charges) | --0 | ---1.48M | ---- | ---6.19M | ---6.19M | --0 | --0 | ---- | --0 | ---- |
| -Less：Restructuring and merger&acquisition | --0 | --1.48M | ---- | --6.19M | --6.19M | --0 | --0 | ---- | --0 | ---- |
| Income before tax | 12.08%-20.31M | 11.36%-21.55M | 2.44%-21.66M | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M |
| Income tax | ||||||||||
| Net income | 12.08%-20.31M | 11.36%-21.55M | 2.44%-21.66M | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M |
| Net income continuous Operations | 12.08%-20.31M | 11.36%-21.55M | 2.44%-21.66M | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 12.08%-20.31M | 11.36%-21.55M | 2.44%-21.66M | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 12.08%-20.31M | 11.36%-21.55M | 2.44%-21.66M | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M |
| Basic earnings per share | 12.58%-2.78 | 11.76%-3 | 3.23%-3 | -38.61%-14 | -76.00%-4.4 | -27.20%-3.18 | -36.00%-3.4 | -19.23%-3.1 | 2.88%-10.1 | 0.00%-2.5 |
| Diluted earnings per share | 12.58%-2.78 | 11.76%-3 | 3.23%-3 | -38.61%-14 | -76.00%-4.4 | -27.20%-3.18 | -36.00%-3.4 | -19.23%-3.1 | 2.88%-10.1 | 0.00%-2.5 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data